With great interest, we have read a recent article entitled ''Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis'', which was published online in Breast Cancer Research and Treatment [1] . In this article, Liu et al. conducted a meta-analysis to address the association between the interleukin-1b (IL-1b) gene -511C[T polymorphism and the risk of breast cancer [1] . Their results showed that the polymorphism of IL-1b -511C[T was not associated with the risk of breast cancer. It is an extremely valuable study.
Nevertheless, careful examinations of the data reported by Liu et al. (shown in Table 1 of Liu et al.'s paper) [1] reveal two key issues that are worth mentioning. First, the data reported by Liu et al. [1] for the study of Smith et al. [2] did not seem in line with the data from Smith et al.'s original publication [2] . The numbers reported by Smith et al. for the CC and TT genotypes were 60 and 14 among the cases and 87 and 39 among the controls, respectively (shown in Table 2 of Smith et al.'s original publication) [2] . Interestingly, after carefully examining the data reported by Liu et al. [1] , the numbers for the CC and TT genotypes were 14 and 60 among the cases and 39 and 87 among the controls, respectively (shown in Table 1 of Liu et al.'s paper) [1] . Second, the data reported by Liu et al. [1] for the study of Liu et al. [3] did not seem in accord with the data from Liu et al.'s original publication [3] . The numbers reported by Liu et al. [3] for the CC, CT, and TT genotypes were 94, 170, and 101 among the cases and 197, 305, and 129 among the controls, respectively (shown in Table 2 of Liu et al.'s original paper) [3] . Interestingly, after carefully examining the data reported by Liu et al. [1] , the numbers for the CC, CT, and TT genotypes were 197, 305, and 129 among the cases and 94, 170, and 101 among the controls, respectively (shown in Table 1 of Liu et al.'s paper) [1] . Therefore, the above discrepancies imply that the association between the IL-1b -511C[T polymorphism and the risk of breast cancer is not entirely reliable. It is needed to clarify the association between the IL-1b -511C[T polymorphism and the risk of breast cancer comprehensively and objectively. We re-evaluated this association by performing a cumulative meta-analysis based on five studies including 1678 breast cancer cases and 1808 controls. Table 1 lists the general information of the eligible studies included in this cumulative meta-analysis. Table 2 lists the summary cumulative odds ratios (ORs) of the association between the IL-1b -511C[T polymorphism and the risk of breast cancer. We did not observe any significant association between the IL-1b -511C[T polymorphism and the risk of breast cancer under all four genetic models. (Fig. 1a-d) . The publication bias was evaluated by using Begg's test and Egger's test in this study. The results of Begg's test and Egger's test showed that there was no potential publication bias (Table 2) . A sensitivity analysis was carried out to check the stability and reliability of our meta-analysis by sequentially deleting each eligible study. The summary OR was not substantially altered under the genetic model of the T allele versus the C allele (data not shown).
In summary, the results provided by Liu et al. [1] should be interpreted with caution. To reach a definitive conclusion, well-designed studies with larger sample sizes are still needed to examine the association between the IL-1b -511C[T polymorphism and the risk of breast cancer. We hope that this remark will contribute to more accurate elaboration and substantiation of the results presented by Liu et al. [1] . 
